For citations:
Klabukova D.L., Holownia-Voloskova M.E., Davydovskaya M.V., Ermolaeva T.N., Olyushina E.M., Polyakova K.I., Fisun A.G., Grinin M.G., Kokushkin K.A. Ocrelizumab in treatment of primary-progressive multiple sclerosis: systematic review. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2018;(2):29-41. (In Russ.) https://doi.org/10.24411/2588-0519-2018-10042
Email this article 